Cardiac mesenchymal stromal cells are a source of adipocytes in arrhythmogenic cardiomyopathy

E. Sommariva, S. Brambilla, C. Carbucicchio, E. Gambini, V. Meraviglia, A. Dello Russo, F. M. Farina, M. Casella, Valentina Ilaria Maria Catto, G. Pontone, M. Chiesa, Ilaria Stadiotti, E. Cogliati, A. Paolin, N. Ouali Alami, C. Preziuso, G. D'Amati, G. I. Colombo, A. Rossini, M. C. CapogrossiC. Tondo, G. Pompilio

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Aim: Arrhythmogenic cardiomyopathy (ACM) is a genetic disorder mainly due to mutations in desmosomal genes, characterized by progressive fibro-adipose replacement of the myocardium, arrhythmias, and sudden death. It is still unclear which cell type is responsible for fibro-adipose substitution and which molecular mechanisms lead to this structural change. Cardiac mesenchymal stromal cells (C-MSC) are the most abundant cells in the heart, with propensity to differentiate into several cell types, including adipocytes, and their role in ACM is unknown. The aim of the present study was to investigate whether C-MSC contributed to excess adipocytes in patients with ACM. Methods: We found that, in ACM patients' explanted heart sections, cells actively differentiating into adipocytes are of mes-and results: enchymal origin. Therefore, we isolated C-MSC from endomyocardial biopsies of ACM and from not affected by arrhythmogenic cardiomyopathy (NON-ACM) (control) patients. We found that both ACM and control C-MSC express desmosomal genes, with ACM C-MSC showing lower expression of plakophilin (PKP2) protein vs. controls. Arrhythmogenic cardiomyopathy C-MSC cultured in adipogenic medium accumulated more lipid droplets than controls. Accordingly, the expression of adipogenic genes was higher in ACM vs. NON-ACM C-MSC, while expression of cell cycle and anti-adipogenic genes was lower. Both lipid accumulation and transcription reprogramming were dependent on PKP2 deficiency. Conclusions: Cardiac mesenchymal stromal cells contribute to the adipogenic substitution observed in ACM patients' hearts. Moreover, C-MSC from ACM patients recapitulate the features of ACM adipogenesis, representing a novel, scalable, patient-specific in vitro tool for future mechanistic studies.

Original languageEnglish
Pages (from-to)1835-1846
Number of pages12
JournalEuropean Heart Journal
Volume57
Issue number23
DOIs
Publication statusPublished - 2016

Fingerprint

Mesenchymal Stromal Cells
Cardiomyopathies
Adipocytes
Plakophilins
Genes
Adipogenesis
Inborn Genetic Diseases
Sudden Death
Cardiac Arrhythmias
Myocardium
Cell Cycle

Keywords

  • Adipogenesis
  • Arrhythmogenic cardiomyopathy
  • Fibrofatty substitution
  • Mesenchymal stromal cells
  • Plakoglobin
  • Plakophilin2

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Cardiac mesenchymal stromal cells are a source of adipocytes in arrhythmogenic cardiomyopathy. / Sommariva, E.; Brambilla, S.; Carbucicchio, C.; Gambini, E.; Meraviglia, V.; Dello Russo, A.; Farina, F. M.; Casella, M.; Catto, Valentina Ilaria Maria; Pontone, G.; Chiesa, M.; Stadiotti, Ilaria; Cogliati, E.; Paolin, A.; Ouali Alami, N.; Preziuso, C.; D'Amati, G.; Colombo, G. I.; Rossini, A.; Capogrossi, M. C.; Tondo, C.; Pompilio, G.

In: European Heart Journal, Vol. 57, No. 23, 2016, p. 1835-1846.

Research output: Contribution to journalArticle

@article{1922a162902f4ba3867e7a1d0b7d407a,
title = "Cardiac mesenchymal stromal cells are a source of adipocytes in arrhythmogenic cardiomyopathy",
abstract = "Aim: Arrhythmogenic cardiomyopathy (ACM) is a genetic disorder mainly due to mutations in desmosomal genes, characterized by progressive fibro-adipose replacement of the myocardium, arrhythmias, and sudden death. It is still unclear which cell type is responsible for fibro-adipose substitution and which molecular mechanisms lead to this structural change. Cardiac mesenchymal stromal cells (C-MSC) are the most abundant cells in the heart, with propensity to differentiate into several cell types, including adipocytes, and their role in ACM is unknown. The aim of the present study was to investigate whether C-MSC contributed to excess adipocytes in patients with ACM. Methods: We found that, in ACM patients' explanted heart sections, cells actively differentiating into adipocytes are of mes-and results: enchymal origin. Therefore, we isolated C-MSC from endomyocardial biopsies of ACM and from not affected by arrhythmogenic cardiomyopathy (NON-ACM) (control) patients. We found that both ACM and control C-MSC express desmosomal genes, with ACM C-MSC showing lower expression of plakophilin (PKP2) protein vs. controls. Arrhythmogenic cardiomyopathy C-MSC cultured in adipogenic medium accumulated more lipid droplets than controls. Accordingly, the expression of adipogenic genes was higher in ACM vs. NON-ACM C-MSC, while expression of cell cycle and anti-adipogenic genes was lower. Both lipid accumulation and transcription reprogramming were dependent on PKP2 deficiency. Conclusions: Cardiac mesenchymal stromal cells contribute to the adipogenic substitution observed in ACM patients' hearts. Moreover, C-MSC from ACM patients recapitulate the features of ACM adipogenesis, representing a novel, scalable, patient-specific in vitro tool for future mechanistic studies.",
keywords = "Adipogenesis, Arrhythmogenic cardiomyopathy, Fibrofatty substitution, Mesenchymal stromal cells, Plakoglobin, Plakophilin2",
author = "E. Sommariva and S. Brambilla and C. Carbucicchio and E. Gambini and V. Meraviglia and {Dello Russo}, A. and Farina, {F. M.} and M. Casella and Catto, {Valentina Ilaria Maria} and G. Pontone and M. Chiesa and Ilaria Stadiotti and E. Cogliati and A. Paolin and {Ouali Alami}, N. and C. Preziuso and G. D'Amati and Colombo, {G. I.} and A. Rossini and Capogrossi, {M. C.} and C. Tondo and G. Pompilio",
year = "2016",
doi = "10.1093/eurheartj/ehv579",
language = "English",
volume = "57",
pages = "1835--1846",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "23",

}

TY - JOUR

T1 - Cardiac mesenchymal stromal cells are a source of adipocytes in arrhythmogenic cardiomyopathy

AU - Sommariva, E.

AU - Brambilla, S.

AU - Carbucicchio, C.

AU - Gambini, E.

AU - Meraviglia, V.

AU - Dello Russo, A.

AU - Farina, F. M.

AU - Casella, M.

AU - Catto, Valentina Ilaria Maria

AU - Pontone, G.

AU - Chiesa, M.

AU - Stadiotti, Ilaria

AU - Cogliati, E.

AU - Paolin, A.

AU - Ouali Alami, N.

AU - Preziuso, C.

AU - D'Amati, G.

AU - Colombo, G. I.

AU - Rossini, A.

AU - Capogrossi, M. C.

AU - Tondo, C.

AU - Pompilio, G.

PY - 2016

Y1 - 2016

N2 - Aim: Arrhythmogenic cardiomyopathy (ACM) is a genetic disorder mainly due to mutations in desmosomal genes, characterized by progressive fibro-adipose replacement of the myocardium, arrhythmias, and sudden death. It is still unclear which cell type is responsible for fibro-adipose substitution and which molecular mechanisms lead to this structural change. Cardiac mesenchymal stromal cells (C-MSC) are the most abundant cells in the heart, with propensity to differentiate into several cell types, including adipocytes, and their role in ACM is unknown. The aim of the present study was to investigate whether C-MSC contributed to excess adipocytes in patients with ACM. Methods: We found that, in ACM patients' explanted heart sections, cells actively differentiating into adipocytes are of mes-and results: enchymal origin. Therefore, we isolated C-MSC from endomyocardial biopsies of ACM and from not affected by arrhythmogenic cardiomyopathy (NON-ACM) (control) patients. We found that both ACM and control C-MSC express desmosomal genes, with ACM C-MSC showing lower expression of plakophilin (PKP2) protein vs. controls. Arrhythmogenic cardiomyopathy C-MSC cultured in adipogenic medium accumulated more lipid droplets than controls. Accordingly, the expression of adipogenic genes was higher in ACM vs. NON-ACM C-MSC, while expression of cell cycle and anti-adipogenic genes was lower. Both lipid accumulation and transcription reprogramming were dependent on PKP2 deficiency. Conclusions: Cardiac mesenchymal stromal cells contribute to the adipogenic substitution observed in ACM patients' hearts. Moreover, C-MSC from ACM patients recapitulate the features of ACM adipogenesis, representing a novel, scalable, patient-specific in vitro tool for future mechanistic studies.

AB - Aim: Arrhythmogenic cardiomyopathy (ACM) is a genetic disorder mainly due to mutations in desmosomal genes, characterized by progressive fibro-adipose replacement of the myocardium, arrhythmias, and sudden death. It is still unclear which cell type is responsible for fibro-adipose substitution and which molecular mechanisms lead to this structural change. Cardiac mesenchymal stromal cells (C-MSC) are the most abundant cells in the heart, with propensity to differentiate into several cell types, including adipocytes, and their role in ACM is unknown. The aim of the present study was to investigate whether C-MSC contributed to excess adipocytes in patients with ACM. Methods: We found that, in ACM patients' explanted heart sections, cells actively differentiating into adipocytes are of mes-and results: enchymal origin. Therefore, we isolated C-MSC from endomyocardial biopsies of ACM and from not affected by arrhythmogenic cardiomyopathy (NON-ACM) (control) patients. We found that both ACM and control C-MSC express desmosomal genes, with ACM C-MSC showing lower expression of plakophilin (PKP2) protein vs. controls. Arrhythmogenic cardiomyopathy C-MSC cultured in adipogenic medium accumulated more lipid droplets than controls. Accordingly, the expression of adipogenic genes was higher in ACM vs. NON-ACM C-MSC, while expression of cell cycle and anti-adipogenic genes was lower. Both lipid accumulation and transcription reprogramming were dependent on PKP2 deficiency. Conclusions: Cardiac mesenchymal stromal cells contribute to the adipogenic substitution observed in ACM patients' hearts. Moreover, C-MSC from ACM patients recapitulate the features of ACM adipogenesis, representing a novel, scalable, patient-specific in vitro tool for future mechanistic studies.

KW - Adipogenesis

KW - Arrhythmogenic cardiomyopathy

KW - Fibrofatty substitution

KW - Mesenchymal stromal cells

KW - Plakoglobin

KW - Plakophilin2

UR - http://www.scopus.com/inward/record.url?scp=84976262194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976262194&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehv579

DO - 10.1093/eurheartj/ehv579

M3 - Article

AN - SCOPUS:84976262194

VL - 57

SP - 1835

EP - 1846

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 23

ER -